Invitae acquiring CombiMatrix and Good Start, raises $73.5M

Genetic testing company Invitae Corp. (NYSE:NVTA) said it is acquiring two diagnostic companies and raised $73.5 million in a private placement.

Invitae will acquire reproductive health diagnostics company CombiMatrix Corp. (NASDAQ:CBMX) for $27 million through the sale of 2.9 million Invitae shares. CombiMatrix provides miscarriage analysis and genetic testing using single nucleotide polymorphism chromosomal microarray analysis and next-generation sequencing. In 2016, CombiMatrix reported $12.8 million in 2016 revenue. Invitae expects the deal to close next quarter...